Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …

Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …